Literature DB >> 12617997

Ribotoxic stress activates p38 and JNK kinases and modulates the antigen-presenting activity of dendritic cells.

Peter Bunyard1, Matthew Handley, Gabriel Pollara, Karine Rutault, Isabelle Wood, Manika Chaudry, Charles Alderman, John Foreman, David R Katz, Benjamin M Chain.   

Abstract

Initiation of adaptive immunity requires activation of dendritic cells (DC) by "danger" signals. This study examines the functional consequences of activating a cellular stress response in human DC. Anisomycin, a potent inducer of this "stress" response, selectively activates p38 kinase in DC at low concentrations, and both p38 kinases and JNKs at higher concentrations. Activation of p38, was accompanied by an increase in the potency of dendritic cells to activate T cells. In contrast to LPS, anisomycin had no effect on the expression of several DC activation markers. Anisomycin synergised with LPS in driving release of IL-12 and TNF-alpha. Anisomycin also enhanced the formation of clusters between DC and T cells. Enhanced cytokine release and clustering were both inhibited by the selective p38 alpha and p38 beta inhibitor SB203580. This study demonstrates that the cellular stress response, mediated via p38 kinases, plays an important role in the regulation of several aspects of DC function. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12617997     DOI: 10.1016/s0161-5890(02)00262-6

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

1.  IL-10 producing CD8+ CD122+ PD-1+ regulatory T cells are expanded by dendritic cells silenced for Allograft Inflammatory Factor-1.

Authors:  Diana M Elizondo; Temesgen E Andargie; Naomi L Haddock; Ricardo L Louzada da Silva; Tatiana Rodrigues de Moura; Michael W Lipscomb
Journal:  J Leukoc Biol       Date:  2018-12-04       Impact factor: 4.962

Review 2.  Cell Signaling Pathways That Regulate Antigen Presentation.

Authors:  Randy R Brutkiewicz
Journal:  J Immunol       Date:  2016-10-15       Impact factor: 5.422

3.  Mechanisms for ribotoxin-induced ribosomal RNA cleavage.

Authors:  Kaiyu He; Hui-Ren Zhou; James J Pestka
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-27       Impact factor: 4.219

4.  P38 mitogen-activated protein kinase activity is required during mitosis for timely satisfaction of the mitotic checkpoint but not for the fidelity of chromosome segregation.

Authors:  Kyunghee Lee; Alison E Kenny; Conly L Rieder
Journal:  Mol Biol Cell       Date:  2010-05-12       Impact factor: 4.138

5.  The G2 p38-mediated stress-activated checkpoint pathway becomes attenuated in transformed cells.

Authors:  Alexei Mikhailov; Daksha Patel; Dennis J McCance; Conly L Rieder
Journal:  Curr Biol       Date:  2007-11-29       Impact factor: 10.834

6.  Deoxynivalenol induces p38 interaction with the ribosome in monocytes and macrophages.

Authors:  Hee Kyong Bae; James J Pestka
Journal:  Toxicol Sci       Date:  2008-05-22       Impact factor: 4.849

Review 7.  Mucosal injuries due to ribosome-inactivating stress and the compensatory responses of the intestinal epithelial barrier.

Authors:  Yuseok Moon
Journal:  Toxins (Basel)       Date:  2011-10-20       Impact factor: 4.546

8.  Minor introns are embedded molecular switches regulated by highly unstable U6atac snRNA.

Authors:  Ihab Younis; Kimberly Dittmar; Wei Wang; Shawn W Foley; Michael G Berg; Karen Y Hu; Zhi Wei; Lili Wan; Gideon Dreyfuss
Journal:  Elife       Date:  2013-07-30       Impact factor: 8.140

9.  Chlorella sorokiniana-Induced Activation and Maturation of Human Monocyte-Derived Dendritic Cells through NF-κB and PI3K/MAPK Pathways.

Authors:  Nien-Tzu Chou; Chieh-Fang Cheng; Hsin-Chieh Wu; Chin-Pen Lai; Li-Tsen Lin; I-Horng Pan; Ching-Huai Ko
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-25       Impact factor: 2.629

10.  Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway.

Authors:  Alexei Mikhailov; Mio Shinohara; Conly L Rieder
Journal:  J Cell Biol       Date:  2004-08-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.